1. Home
  2. KNSA vs HP Comparison

KNSA vs HP Comparison

Compare KNSA & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • HP
  • Stock Information
  • Founded
  • KNSA 2015
  • HP 1920
  • Country
  • KNSA United Kingdom
  • HP United States
  • Employees
  • KNSA N/A
  • HP N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • HP Oil & Gas Production
  • Sector
  • KNSA Health Care
  • HP Energy
  • Exchange
  • KNSA Nasdaq
  • HP Nasdaq
  • Market Cap
  • KNSA 1.9B
  • HP 1.9B
  • IPO Year
  • KNSA 2018
  • HP N/A
  • Fundamental
  • Price
  • KNSA $27.36
  • HP $15.25
  • Analyst Decision
  • KNSA Strong Buy
  • HP Hold
  • Analyst Count
  • KNSA 5
  • HP 11
  • Target Price
  • KNSA $38.80
  • HP $27.90
  • AVG Volume (30 Days)
  • KNSA 474.9K
  • HP 2.2M
  • Earning Date
  • KNSA 07-22-2025
  • HP 05-07-2025
  • Dividend Yield
  • KNSA N/A
  • HP 6.56%
  • EPS Growth
  • KNSA N/A
  • HP N/A
  • EPS
  • KNSA N/A
  • HP 2.20
  • Revenue
  • KNSA $481,166,000.00
  • HP $3,084,858,000.00
  • Revenue This Year
  • KNSA $37.21
  • HP $37.71
  • Revenue Next Year
  • KNSA $5.32
  • HP $4.61
  • P/E Ratio
  • KNSA N/A
  • HP $6.94
  • Revenue Growth
  • KNSA 59.45
  • HP 12.23
  • 52 Week Low
  • KNSA $17.38
  • HP $14.65
  • 52 Week High
  • KNSA $28.56
  • HP $42.60
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 62.48
  • HP 28.54
  • Support Level
  • KNSA $26.28
  • HP $15.03
  • Resistance Level
  • KNSA $27.90
  • HP $15.71
  • Average True Range (ATR)
  • KNSA 0.99
  • HP 0.66
  • MACD
  • KNSA -0.07
  • HP -0.09
  • Stochastic Oscillator
  • KNSA 82.30
  • HP 10.91

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.

Share on Social Networks: